Medicare Enrolled

Dr. Mary Kalafut, M.D.

Neurology · La Jolla, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
9898 GENESEE AVE, La Jolla, CA 92037
8588245400
In practice since 2006 (20 years)
NPI: 1720048663 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kalafut from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kalafut? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kalafut

Dr. Mary Kalafut is a neurology specialist in La Jolla, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kalafut performed 1,417 Medicare services across 1,352 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kalafut received a total of $8,334 from 59 pharmaceutical and/or device companies across 425 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kalafut is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 25% volume in CA $8,334 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,417
Medicare services
Top 25% in CA for neurology
1,352
Unique beneficiaries
$121
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~71 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Ultrasound of arm or leg veins
An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages.
356 $102 $495
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
226 $103 $350
Ultrasound of head and neck blood flow, bilateral
An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck.
221 $161 $791
Ultrasound of arm or leg veins
An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers.
214 $165 $779
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
134 $129 $453
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
133 $68 $248
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
94 $87 $305
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
39 $152 $491
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,334
Total received (2018-2024)
Avg $1,191/year across 7 years
Top 25% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
425
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,734 (92.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$600 (7.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,150
2023
$1,368
2022
$1,242
2021
$463
2020
$1,056
2019
$1,703
2018
$1,352

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$347
PFIZER INC.
$153
ARGENX US, INC.
$107
Lundbeck LLC
$83
UCB, Inc.
$83
Amgen Inc.
$81
SK Life Science, Inc.
$73
Lilly USA, LLC
$37
Alnylam Pharmaceuticals Inc.
$25
CATALYST PHARMACEUTICALS, INC.
$25
SCILEX PHARMACEUTICALS INC.
$24
GE HEALTHCARE
$23
Grifols USA, LLC
$21
Amneal Pharmaceuticals LLC
$21
Biogen, Inc.
$17
Celgene Corporation
$16
Teva Pharmaceuticals USA, Inc.
$15
Top 3 companies account for 52.8% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,638
Medtronic Vascular, Inc.
$860
Amgen Inc.
$535
GE HEALTHCARE
$398
Sunovion Pharmaceuticals Inc.
$365
Lundbeck LLC
$356
PFIZER INC.
$255
CSL Behring
$251
UCB, Inc.
$250
Avanir Pharmaceuticals, Inc.
$201
Lilly USA, LLC
$182
ARGENX US, INC.
$179
Novartis Pharmaceuticals Corporation
$174
Alexion Pharmaceuticals, Inc.
$159
Biohaven Pharmaceutical Holding Company Ltd.
$156
AbbVie Inc.
$156
Teva Pharmaceuticals USA, Inc.
$151
Allergan Inc.
$149
Promius Pharma LLC
$137
Allergan, Inc.
$131
Chiesi USA, Inc.
$114
Supernus Pharmaceuticals, Inc.
$99
UPSHER-SMITH LABORATORIES LLC
$96
PORTOLA PHARMACEUTICALS, INC.
$85
SK Life Science, Inc.
$73
Akcea Therapeutics, Inc.
$72
Upsher-Smith Laboratories LLC
$70
Grifols USA, LLC
$64
GE HealthCare
$60
Merz North America, Inc.
$55
AstraZeneca Pharmaceuticals LP
$51
Amneal Pharmaceuticals LLC
$47
Alnylam Pharmaceuticals Inc.
$46
Corium, LLC
$45
Janssen Pharmaceuticals, Inc
$45
ACADIA Pharmaceuticals Inc
$45
Biohaven Pharmaceuticals, Inc.
$44
Bausch Health US, LLC
$41
Merz Pharmaceuticals, LLC
$41
Adamas Pharmaceuticals, Inc.
$40
Ipsen Biopharmaceuticals, Inc
$39
Vanda Pharmaceuticals Inc.
$32
EMD Serono, Inc.
$29
Takeda Pharmaceuticals U.S.A., Inc.
$29
Neurelis, Inc.
$28
Boston Scientific Corporation
$27
CATALYST PHARMACEUTICALS, INC.
$25
EISAI INC.
$24
SCILEX PHARMACEUTICALS INC.
$24
Scilex Pharmaceuticals Inc.
$22
Eisai Inc.
$21
E.R. Squibb & Sons, L.L.C.
$18
Biogen, Inc.
$17
Genentech USA, Inc.
$16
IMPEL PHARMACEUTICALS INC.
$16
Celgene Corporation
$16
Egalet US Inc
$12
Assertio Therapeutics, Inc.
$11
Impax Laboratories, Inc.
$11
Top 3 companies account for 36.4% of all-time payments
Associated products mentioned in payments ›
AFINITOR · AIMOVIG · AJOVY · AMVUTTRA · AMYVID · ANDEXXA · APTIOM · Adlarity · Aimovig · BOTOX · BRILINTA · Briviact · CAMBIA · CLEVIPREX · Dysport · ELIQUIS · EMGALITY · FYCOMPA · Fycompa · GAMMAGARD · GENERAL DBS · GOCOVRI · Gamunex-C · HETLIOZ · Hizentra · KISUNLA · LEQEMBI · MAYZENT · MIGRANAL · Mavenclad · NUEDEXTA · NUPLAZID · NURTEC ODT · Nuedexta · ONPATTRO · OXTELLAR XR · Privigen · QULIPTA · RYTARY · Reveal LINQ · SOLIRIS · SPRIX · TEGSEDI · TOSYMRA · TROKENDI XR · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · XARELTO · XEOMIN · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZOMIG · ZTLido · Zembrace · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in La Jolla?
Compare neurologists in the La Jolla area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
195
Per 100K population
5.9
County median income
$102,285
Nearest hospital
SCRIPPS MEMORIAL HOSPITAL LA JOLLA
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kalafut is a clinical cardiology specialist, with above-average Medicare volume (top 25% in CA), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kalafut experienced with ultrasound of arm or leg veins?
Based on Medicare claims data, Dr. Kalafut performed 356 ultrasound of arm or leg veins services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kalafut receive payments from pharmaceutical companies?
Yes. Dr. Kalafut received a total of $8,334 from 59 companies across 425 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kalafut's costs compare to other neurologists in La Jolla?
Dr. Kalafut's average Medicare payment per service is $121. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kalafut) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →